MONDAY, Dec. 12, 2022 (HealthDay News) An experimental immunotherapy appears highly effective in attacking bone marrow cancer, with nearly three in four patients responding to the treatment, new clinical
Antibody Treatment Makes Inroads Against Multiple Myeloma averyjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from averyjournal.com Daily Mail and Mail on Sunday newspapers.
Antibody Treatment Makes Inroads Against Multiple Myeloma westcentralsbest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from westcentralsbest.com Daily Mail and Mail on Sunday newspapers.
An antibody infusion could be a game changer for people with persistent multiple myeloma, an aggressive blood cancer. The therapy was successful about 73 per cent of the time.
Get latest articles and stories on Health at LatestLY. The treatment, which is referred to as a "bispecific antibody," binds to both T cells and multiple myeloma cells and instructs the T cells, which are white blood cells that can be used to fight off diseases Health News | Experimental Cancer Therapy Shows 73 Pc Success Rate in Trials: Study.